Prioritising tool(s) for measuring chronic pain-related outcomes as part of the pharmacotherapy service in Scotland: a patient consensus study

The findings will facilitate decision making regarding the delivery of pharmacotherapy chronic pain services in Scotland. There is a preference for a disease-specific tool, however a combination of the BPI and the more general EQ-5D-5L could be used to capture more insight into the impact of the service on patients. Future work should test these tools in diverse populations and explore the use of the EQ-5D-5L with condition-specific tools for patients with various chronic conditions.